| Jinesh Mehta, MD | |
|
2950 Cleveland Clinic Blvd, Pulmonary Medicine, Weston, FL 33331-3609 | |
| (954) 659-5450 | |
| (954) 659-5451 |
| Full Name | Jinesh Mehta |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 25 Years |
| Location | 2950 Cleveland Clinic Blvd, Weston, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619918232 | NPI | - | NPPES |
| 003999800 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | ME110584 (Florida) | Primary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | ME110584 (Florida) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic Hospital | Weston, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Florida A Nonprofit Corporation | 7911807128 | 618 |
News Archive
Scientists are reporting the strongest evidence to date that neurodegenerative diseases target and progress along distinct neural networks that normally support healthy brain function.
Medullary cystic kidney disease type 1 (MCKD1) is a rare genetic kidney disease. Despite this, because it is an autosomal dominant disease, once the mutation is in a family, many family members are affected. Current diagnostic methods discover the disease late in its development.
North West London Pathology, hosted by Imperial College Healthcare NHS Trust, and Abbott announced today that they signed a $252 million managed equipment services contract for the supply of all analytical equipment and consumables, including Abbott's Alinity ci and Alinity h series diagnostics instruments as well as their professional services and informatics solutions known as AlinIQ.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that it has submitted a 510(k) application to the United States Food and Drug Administration (FDA) to obtain marketing clearance for the use of its Duratech(TM) BioRegeneration Matrix to repair or replace the dura mater (the outermost membrane surrounding the brain) in various cranial surgical procedures.
Nuvilex, Inc., an emerging biotechnology provider of cell and gene therapy solutions, today provided additional details based on the Goldman Small Cap Research report issued February 29, 2012, that highlighted the company's cell encapsulation technology and its benefits for treating chronic diseases such as diabetes.
› Verified 7 days ago
| Entity Name | Cleveland Clinic Florida A Nonprofit Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215989298 PECOS PAC ID: 7911807128 Enrollment ID: O20040113000394 |
News Archive
Scientists are reporting the strongest evidence to date that neurodegenerative diseases target and progress along distinct neural networks that normally support healthy brain function.
Medullary cystic kidney disease type 1 (MCKD1) is a rare genetic kidney disease. Despite this, because it is an autosomal dominant disease, once the mutation is in a family, many family members are affected. Current diagnostic methods discover the disease late in its development.
North West London Pathology, hosted by Imperial College Healthcare NHS Trust, and Abbott announced today that they signed a $252 million managed equipment services contract for the supply of all analytical equipment and consumables, including Abbott's Alinity ci and Alinity h series diagnostics instruments as well as their professional services and informatics solutions known as AlinIQ.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that it has submitted a 510(k) application to the United States Food and Drug Administration (FDA) to obtain marketing clearance for the use of its Duratech(TM) BioRegeneration Matrix to repair or replace the dura mater (the outermost membrane surrounding the brain) in various cranial surgical procedures.
Nuvilex, Inc., an emerging biotechnology provider of cell and gene therapy solutions, today provided additional details based on the Goldman Small Cap Research report issued February 29, 2012, that highlighted the company's cell encapsulation technology and its benefits for treating chronic diseases such as diabetes.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jinesh Mehta, MD 2950 Cleveland Clinic Blvd, Pulmonary Medicine, Weston, FL 33331-3609 Ph: (954) 659-5450 | Jinesh Mehta, MD 2950 Cleveland Clinic Blvd, Pulmonary Medicine, Weston, FL 33331-3609 Ph: (954) 659-5450 |
News Archive
Scientists are reporting the strongest evidence to date that neurodegenerative diseases target and progress along distinct neural networks that normally support healthy brain function.
Medullary cystic kidney disease type 1 (MCKD1) is a rare genetic kidney disease. Despite this, because it is an autosomal dominant disease, once the mutation is in a family, many family members are affected. Current diagnostic methods discover the disease late in its development.
North West London Pathology, hosted by Imperial College Healthcare NHS Trust, and Abbott announced today that they signed a $252 million managed equipment services contract for the supply of all analytical equipment and consumables, including Abbott's Alinity ci and Alinity h series diagnostics instruments as well as their professional services and informatics solutions known as AlinIQ.
Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that it has submitted a 510(k) application to the United States Food and Drug Administration (FDA) to obtain marketing clearance for the use of its Duratech(TM) BioRegeneration Matrix to repair or replace the dura mater (the outermost membrane surrounding the brain) in various cranial surgical procedures.
Nuvilex, Inc., an emerging biotechnology provider of cell and gene therapy solutions, today provided additional details based on the Goldman Small Cap Research report issued February 29, 2012, that highlighted the company's cell encapsulation technology and its benefits for treating chronic diseases such as diabetes.
› Verified 7 days ago
Dr. Chirayu Trivedi, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3250 Meridian Pkwy, Weston, FL 33331 Phone: 954-659-5867 Fax: 954-659-5354 | |
Manju R Morrissey, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2200 N Commerce Pkwy, Weston, FL 33326 Phone: 954-331-3545 | |
Vineeth Mohan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000 Fax: 954-659-6039 | |
Sarah Abbas, Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-6161 Fax: 954-659-5425 | |
Dr. Saad Majzoub Sabbagh, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-6161 | |
Radhika Salwan, DO, MS Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000 | |
Dr. Stephen Garrett Marcus, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 1792 Bell Tower Ln, Weston, FL 33326 Phone: 954-315-3660 Fax: 954-315-3661 |